ArticleFrontiers in neurology2026

Early high-dose intravenous methylprednisolone is associated with faster symptom improvement in persistent ocular myasthenia gravis: a single-center retrospective study.

Noritaka Matsuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.